ABEONA THERAPEUTICS INC. Dividends Payable, Current
ABEONA THERAPEUTICS INC. (ABEO) had Dividends Payable, Current of $0 as of 2014-12-31, per its 10-K filed 2015-03-31.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:DividendsPayableCurrent · last filed 2015-03-31
- 2014-12-31: Dividends Payable, Current $0.00.
- 2014-09-30: Dividends Payable, Current $9.28M.
- 2014-06-30: Dividends Payable, Current $8.37M.
- 2014-03-31: Dividends Payable, Current $7.51M.
| Period end | Dividends Payable, Current |
|---|---|
| 2014-12-31 | $0.00 10-K · filed 2015-03-31 |
| 2014-09-30 | $9.28M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $8.37M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $7.51M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $6.66M 10-K · filed 2015-03-31 |
| 2013-09-30 | $5.87M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $5.03M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $4.26M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $3.49M 10-K · filed 2014-03-26 |
| 2012-09-30 | $2.77M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $7.52M 10-Q · filed 2012-08-14 |
| 2012-03-31 | $7.00M 10-Q · filed 2012-05-15 |
| 2011-12-31 | $6.49M 10-K · filed 2013-03-20 |
| 2011-09-30 | $5.97M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $5.45M 10-Q · filed 2011-08-15 |
| 2010-12-31 | $4.44M 10-K · filed 2012-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |